Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptor.

American journal of hypertension - 1 Nov 2005

Masuo Kazuko, Katsuya Tomohiro, Kawaguchi Hideki, Fu Yuxiao, Rakugi Hiromi, Ogihara Toshio, Tuck Michael L

Abstract excerpt

BACKGROUND: A successful weight loss program is essential treatment for obesity-related diseases, but it is well known that the majority of individuals do not succeed in weight loss maintenance. The present study evaluates hormonal mechanisms and the relationship of beta2-adrenoceptor polymorphis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Eating
Share to Heart Rate
Share to Norepinephrine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Overweight

Share to Receptors, Adrenergic, beta-2

Share to Receptors, Adrenergic, beta-3

Share to Weight Gain

Share to Weight Loss

Source

Identifiers

PMID: 16280290
DOI: 10.1016/j.amjhyper.2005.05.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-16280290-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptor.PMID 16280290Read ↗

beta2- and beta3-Adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals.Semantic proximity Read ↗

Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.Semantic proximity Read ↗

Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation.Semantic proximity Read ↗

Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.Semantic proximity Read ↗

High plasma norepinephrine levels associated with beta2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals.Semantic proximity Read ↗

Influence of ADRB2 Gln27Glu and ADRB3 Trp64Arg polymorphisms on body weight and body composition changes after a controlled weight-loss intervention.Semantic proximity Read ↗

Relation of weight maintenance and dietary restraint to peroxisome proliferator-activated receptor gamma2, glucocorticoid receptor, and ciliary neurotrophic factor polymorphisms.Semantic proximity Read ↗

Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the beta3-adrenergic receptor gene.Semantic proximity Read ↗

Association of a beta-2 adrenoceptor (ADRB2) gene variant with a blunted in vivo lipolysis and fat oxidation.Semantic proximity Read ↗

Association of cholecystokinin 1 receptor and beta3-adrenergic receptor polymorphisms with midlife weight gain.Semantic proximity Read ↗

Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight.Semantic proximity Read ↗

Impact of Polymorphism in the β2-Receptor Gene on the Metabolic Response to Epinephrine After Repeated Hypoglycemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.